[an error occurred while processing this directive] ����Ƥ���Բ�ѧ��־ 2004, 30(3) 158-160 DOI:     ISSN: 2096-5540 CN: 32-1880/R

����Ŀ¼ | ����Ŀ¼ | ������� | �߼�����                                                            [��ӡ��ҳ]   [�ر�]
����
��չ����
������Ϣ
Supporting info
PDFȫ��
[HTMLȫ��]
�����
�����뷴��
�ѱ����Ƽ�������
�����ҵ����
�������ù�����
����
Email Alert
���·���
���������Ϣ
���Ĺؼ����������
ҩ��
�����о�
�����آ���
���������������
����
������
PubMed
Article by
Article by

��-�������ͷ�ʵ����ҩ������е�����

����, ������

������ѧ������ɽҽԺƤ���� �Ϻ� 200040

ժҪ��

ҩ��ķ�����Tϸ���������,Tϸ�����͡�ϸ�������ͷ�;�����п���Ӱ������Ӧ������͡�����������ҩ�����ڳٷ��ͱ�̬��Ӧ,����-�������dzٷ��ͱ�̬��Ӧ�е�һ����Ҫ����,��-�������ͷ�ʵ���ԭ����ǽ�ҩ����������ܰ�ϸ�����������������ҩ�ﹲͬ����,���߿ɴ̼�Tϸ�������϶�Ħ�-������,ͨ��ELISA�����ⶨ����������ȷҩ�������ҩ�

�ؼ����� ҩ��   �����о�   �����آ���  

Abstract:

Keywords:
�ո����� 2003-08-09 �޻�����  ����淢������  
DOI:
������Ŀ:

ͨѶ����:
���߼��:

�ο����ף�
[1] Milavec-Puretic V, Lipozencic J, Vuksic D, et al. Cutaneous symptons and diagnosis of drug hypersensitivity. Lijec Vjesn, 1994, 116:83-87.
[2] Livni E, Lapidoth M, Halevy S. In vitro release of interferon-gamma and macrophage migration inhibition factor in drug-induced urticaria and angioedema. Acta Derm Venereol, 1999, 79:18-22.
[3] Halevy S, Livni E. The role of macrophage migration inhibition factor in toxic epidermal necrolysis. Int J Dermatol, 1997, 36:776-778.
[4] Rocklin RE. Products of activated lymphocytes: leukocyte inhibitory factor (LIF) distinct from migration inhibitory factor(MIF). J Immunol, 1974, 112:1461-1466.
[5] Hertl M, Merk HF. lymphocyte activation in cutaneous drug reactions. J Invest Dermatol, 1995, 105:S95-S98.
[6] Hertl M, Geisel J, Boecker C, et al. Selective generation of CD8 +T-cell clones from the peripheral blood of patients with cutaneous reactions to beta-lactam antibiotics. Br J Dermatol, 1993, 128:619.
[7] Halevy S, Cohen A, Livui E. Acute generalized exanthenatous pustulosis associated with polysensitivity to paracetanol and bromhexine:the diagnostic role of in vitro interferon-gamma release test. Clin Exp Dermatol, 2000, 25:652-654.
[8] Halevy S; Cohen AID, Livni E. The diagnostic role of the in vitro drug-induced interferon-gamma release test in Stevens-Johnson syndrome, Int J Dermatol, 1999, 38:835-840.
[9] Koga T, Imayama S, Hori Y. In vitro release of interferon-gamma by peripheral blood mononuclear cells of a patient with carbamazepine-induced allergic drug eruption in response to stimulation with carbamazepine. Contact Dermatitis, 1995, 32:181-182.
[10] Halevy S, Cohen AD, Grossman N. In vitro interferon-gamma releasea laboratory diagnosis of cutaneous adverse drug reactions. Harefuah,2001, 140:121-124, 190.
[11] Cohen AD, Cagnano E, Halevy S. Acute generalized exanthematous pustulosis mimicking toxic epidermal necrolysis. Int J Dermatol,2001,40:458-461.
[12] Nadal D. Is the in vitro interferon-gamma release assay an adequate replacement for the tuberculin skin test? Clin Infect Dis, 2002, 34:1457-1459.
�������������
1��ʯƽ��,�,����Ⱥ,.ҩ�ﳬ����Ӧ�ۺ����������Ƽ����Ƶ��о���չ[J]. ����Ƥ���Բ�ѧ��־, 2006,32(2): 117-
2��������,���.��֢������ҩ�����߻��Ƽ��������ƽ�չ[J]. ����Ƥ���Բ�ѧ��־, 2008,34(2): 78-80
3����ľ��,�����,����,������.���Ѵ�����ҩ��52������[J]. ����Ƥ���Բ�ѧ��־, 2008,34(6): 348-350
4��������,�Ű�ƽ.ҩ���������ϸ����ԭ������о���չ[J]. ����Ƥ���Բ�ѧ��־, 2008,34(6): 368-370
5���ε��� ¬����.��Ƥ���������������Ƽ���Ƥ����Ӧ������[J]. ����Ƥ���Բ�ѧ��־, 2010,36(6): 322-324
6������������, �������У.Ѫ�������Ʒ���Ƥ���Ƶ�Ӧ��[J]. ����Ƥ���Բ�ѧ��־, 1995,21(6): 345-346
7����������, ��ѧ����У.�ж��Ա�Ƥ�����ɽ�֢�ķ�������[J]. ����Ƥ���Բ�ѧ��־, 0,(): 75-78
8������Ӣ����, ������У.������ҩ��[J]. ����Ƥ���Բ�ѧ��־, 2001,27(5): 305-307
9����������, ��ѧ����У.�ж��Ա�Ƥ�����ɽ�֢�ķ�������[J]. ����Ƥ���Բ�ѧ��־, 1997,23(2): 75-78

�������� (��ע��:��վʵ�������Ը�, �벻Ҫ������ѧ���޹ص�����!�������ݲ�����վ�۵�.)

Copyright 2008 by ����Ƥ���Բ�ѧ��־